Building on the insights from our previous seminar on licensing within the pharmaceutical industry, we delve deeper into the critical processes and vital intellectual property (IP) aspects of in-licensing, due diligence (DD) and mergers & acquisitions (M&A).

Hear from experts in the field: Tomas Lundquist, Vice President, Head of IP at Sobi, Ulrika Munter, Senior Patent Counsel at Sobi and Malcolm Wiberg, Legal Director at Alvotech.

The discussion will be moderated by Louise Jonshammar, Partner and Attorney at Law at AWA.